MedTrace Logo

Low Dose Whole Lung Radiotherapy for Older Patients With COVID-19 Pneumonitis

NCT04493294 · Status: UNKNOWN · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 500

Last updated 2020-07-30

No results posted yet for this study

Summary

Low dose whole lung radiotherapy may improve survival of older patients with COVID-19 pneumonitis

Conditions

  • COVID-19 Pneumonitis

Interventions

RADIATION

Low dose whole lung radiotherapy for older patients with COVID-19 pneumonitis

Low dose whole lung radiotherapy may decrease the cytokines storm related to the viral infection and may improve survival by decreasing the need for artificial ventilation

Sponsors & Collaborators

  • Brigitta G. Baumert

    collaborator UNKNOWN

  • International Geriatric Radiotherapy Group

    lead OTHER

Principal Investigators

  • Brigitta G Baumert, M.D.Ph.D · Institute of Radiation Oncology, Cantonal hospital Graubuenden, Chur, Switzerland

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-11-30
Primary Completion
2021-12-31
Completion
2021-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04493294 on ClinicalTrials.gov